BiopharmaTrend.com

A fresh viewpoint on drug discovery, pharma, and biotech

Subscribe | Become an author | Author LogIn

Website

Contact us at info@biopharmatrend.com to request profile updates/corrections. You must be an official company representative to do so (only requests from corporate emails are accepted).

Numerate

About

We apply our novel AI based platform to small molecule chemical design challenges to increase speed and success while reducing the cost

Year Founded
2007
Geography
United States of America based
Funding
$17.4 M
Field/area focus
Chemistry
Research papers
1
Patents
3
Therapeutic focus
  • Cardiovascular
  • Oncology
  • Neuroscience
Business model
  • own drug discovery programs
  • contract research
Product type
  • small molecules
Research Use Case
  • Preclinical Experiments

Industry Partnerships

YearPartnerFocus
2011Boehringer Ingelheim
2012Merck
2017Takeda

Posts Mentioning This Company

Takeda Partners With Numerate To Use Artificial Intelligence For Drug Discovery - June 17, 2017
New Tools, Products and Technologies
How Big Pharma Adopts AI To Boost Drug Discovery - Oct. 8, 2018
Biopharma Insights
Pharma and Healthcare AI Vendors Join Forces To Accelerate Progress In Drug Discovery - Sept. 12, 2018
Biopharma Insights